Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.75B |
| 2 |
MSLC
Morgan Stanley Pathway Large Cap Equity ETF
MSLC
|
+$2.07B |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$1.75B |
| 4 |
Apple
AAPL
|
+$1.6B |
| 5 |
Tesla
TSLA
|
+$1.58B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.7B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.35B |
| 3 |
Strategy Inc
MSTR
|
+$1.3B |
| 4 |
Shopify
SHOP
|
+$1.14B |
| 5 |
Vanguard Short-Term Bond ETF
BSV
|
+$1.03B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.55% |
| 2 | Financials | 11.55% |
| 3 | Consumer Discretionary | 9.73% |
| 4 | Healthcare | 8.08% |
| 5 | Communication Services | 6.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5276
Listed Funds Trust Roundhill Magnificent Seven ETF
MAGS
$3.83B
| $478K | ﹤0.01% |
8,788
+5,300
| +152% | +$272K |
|
5277
JPMorgan US Momentum Factor ETF
JMOM
$2.6B
| $477K | ﹤0.01% |
8,192
+2,689
| +49% | +$160K |
|
5278
OptimumBank Holdings
OPHC
$108M
| $476K | ﹤0.01% |
100,000
| – | – |
|
5279
DiaMedica Therapeutics
DMAC
$359M
| $475K | ﹤0.01% |
87,429
-22,587
| -21% | -$107K |
|
5280
VictoryShares US Small Cap High Div Volatility Wtd ETF
CSB
$273M
| $474K | ﹤0.01% |
7,979
-1,067
| -12% | -$64.7K |
|
5281
NEOS S&P 500 High Income ETF
SPYI
$11.2B
| $474K | ﹤0.01% |
9,321
+6,177
| +196% | +$320K |
|
|
MPX
5282
DELISTED
Marine Products Corp
MPX
| $473K | ﹤0.01% |
51,573
+7,157
| +16% | +$68.8K |
|
5283
FlexShares Global Quality Real Estate Index Fund
GQRE
$424M
| $472K | ﹤0.01% |
8,285
-123
| -1% | -$7.43K |
|
|
MRCC
5284
DELISTED
Monroe Capital Corp
MRCC
| $472K | ﹤0.01% |
55,540
+549
| +1% | +$4.52K |
|
5285
Barfresh Food Group
BRFH
$28.6M
| $471K | ﹤0.01% |
160,220
+34,720
| +28% | +$92.8K |
|
|
EQC
5286
DELISTED
Equity Commonwealth
EQC
| $470K | ﹤0.01% |
265,279
-804,396
| -75% | -$12.4M |
|
|
OTLY
5287
Oatly Group
OTLY
$445M
| $467K | ﹤0.01% |
35,207
+10,425
| +42% | +$154K |
|
5288
Black Diamond Therapeutics
BDTX
$103M
| $467K | ﹤0.01% |
218,020
+93,016
| +74% | +$267K |
|
5289
Prelude Therapeutics
PRLD
$362M
| $466K | ﹤0.01% |
365,159
+41,470
| +13% | +$55K |
|
5290
YieldMax NVDA Option Income Strategy ETF
NVDY
$1.45B
| $462K | ﹤0.01% |
19,778
+8,440
| +74% | +$210K |
|
5291
Tenax Therapeutics
TENX
$488M
| $461K | ﹤0.01% |
74,445
+74,185
| +28,533% | +$360K |
|
5292
Passage Bio
PASG
$14.8M
| $461K | ﹤0.01% |
40,622
+39,950
| +5,945% | +$520K |
|
5293
Foghorn Therapeutics
FHTX
$287M
| $460K | ﹤0.01% |
97,545
-10,656
| -10% | -$77.6K |
|
5294
BRC Group Holdings
RILY
$298M
| $460K | ﹤0.01% |
100,269
+9,678
| +11% | +$50.5K |
|
|
CCRD
5295
DELISTED
CoreCard
CCRD
| $459K | ﹤0.01% |
20,223
-4,320
| -18% | -$76.5K |
|
5296
Stratus Properties
STRS
$159M
| $459K | ﹤0.01% |
22,110
-2,416
| -10% | -$58.2K |
|
5297
Copel
ELPC
$8.6B
| $459K | ﹤0.01% |
88,005
+25,176
| +40% | +$148K |
|
5298
GrowGeneration
GRWG
$88.9M
| $458K | ﹤0.01% |
271,264
-314,063
| -54% | -$601K |
|
5299
JPMorgan High Yield Municipal ETF
JMHI
$292M
| $458K | ﹤0.01% |
9,125
| – | – |
|
5300
Acumen Pharmaceuticals
ABOS
$162M
| $458K | ﹤0.01% |
266,216
+27,016
| +11% | +$65K |
|
Similar funds
Morgan Stanley's Q4 2024 Portfolio in Review
As of Q4 2024, Morgan Stanley held 8,265 positions worth $1.43T, up 3.5% from $1.38T the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Morgan Stanley's Q4 2024 filing shows 347 new, 3,539 increased, 3,177 reduced and 287 closed positions. Its largest new stake was Morgan Stanley Pathway Large Cap Equity ETF: 42,204,466 shares worth $2.03B. The largest sale was iShares 20+ Year Treasury Bond ETF, an estimated $1.7B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Financials and Consumer Discretionary.
- Morgan Stanley's largest Q4 2024 buy was Morgan Stanley Pathway Large Cap Equity ETF: 42,204,466 shares worth $2.03B.
- Morgan Stanley added most to NVIDIA in Q4 2024, an estimated $2.75B increase.
- Morgan Stanley's biggest Q4 2024 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $1.7B.
- Morgan Stanley fully exited Marathon Oil Corporation in Q4 2024, selling an estimated $259M.
- Morgan Stanley's ten largest holdings make up 22% of its $1.43T portfolio in Q4 2024.
- Morgan Stanley opened 347 new positions and closed 287 in Q4 2024.
- Morgan Stanley's portfolio value rose 3.5% quarter-over-quarter to $1.43T.
Based on Morgan Stanley's 13F filing for Q4 2024, filed 14 Feb 2025.